← SynDRA
ELUXADOLINE
SynDRA canonical compound SYN0033998 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Primary target(s) | OPRD1 | OPRK1 | OPRM1 |
| Mechanism of action | opioid receptor agonist | opioid receptor antagonist |
| Indication | irritable bowel syndrome |
| Disease area | gastroenterology |
All known targets
- OPRM1
- OPRD1
- OPRK1
- Oprd1
- Oprm1
Mechanisms of action (all sources)
- OPRM1 AGONIST
- Mu opioid receptor agonist
- opioid receptor agonist
- opioid receptor antagonist
- OPRM1 MODULATOR
- OPRD1 MODULATOR
- OPRD1 ANTAGONIST
Drug classes
- Gastrointestinal Agents
- Opioid mu-Receptor Agonists
- mu-Opioid Receptor Agonist
ATC classes
Cross-references
Synonyms
- truberzi
- viberzi
- JNJ 27018966
- MuDelta
- Eluxadolina
- JNJ-27018966
- Truberzi
- Viberzi
- eluxadoline (nflis-drug)
- eluxadolina
- CHEBI:85980
- eluxadolinum
- RefChem:58981
- A07DA06
- DTXCID50158080
- MFCD28386164
- Eluxadoline [USAN]
- Eluxadoline [USAN:INN]
- UNII-45TPJ4MBQ1
- Viberzi (TN)
- Eluxadoline deuterated
- ELUXADOLINE [MI]
- ELUXADOLINE [INN]
- Eluxadoline (USAN/INN)
- ELUXADOLINE [WHO-DD]
- orb341556
- GTPL7691
- DEA No. 9725
- ELUXADOLINE [NFLIS-DRUG]
- SCHEMBL12971682
- SCHEMBL17950908
- SCHEMBL19329856
- ELUXADOLINE [ORANGE BOOK]
- GLXC-90464
- EX-A1169
- AKOS030632800
- CCG-270093
- CS-3855
Reported adverse events
- Constipation
- Dizziness
- Flatulence
- Hypersensitivity
- Nausea
- Pancreatitis
- Rash
- Vomiting
- Bronchitis
- Fatigue
- Nasopharyngitis
Look up ELUXADOLINE in the interactive SynDRA portal →